Showing posts with label chronic diseases. Show all posts
Showing posts with label chronic diseases. Show all posts

Thursday, 5 September 2013

Coca-Cola investment in India on track

The original source of this article can be found here.  LIVEMINT(India) Wall Street Journal


Coca-Cola investment in India on track

World’s largest beverage maker to spend $5 billion in India over eight years, setting aside concerns that a slowing economy will affect its investments
Comment E-mail Print  Share 
First Published: Fri, Aug 23 2013. 12 18 AM IST
The company could, after evaluating demand and volume growth, even increase investments if required, Ahmet C. Bozer, executive vice-president of Coca-Cola, said. Photo: Bloomberg
The company could, after evaluating demand and volume growth, even increase investments if required, Ahmet C. Bozer, executive vice-president of Coca-Cola, said. Photo: Bloomberg
New Delhi: Coca-Cola Co., the world’s largest beverage maker, is on track to spend $5 billion in India over eight years, setting aside concerns that a slowing Indian economy would affect the company’s investments.
“Our investments in India are on track as we build scale, manufacturing capacity, distribution capability and a robust product portfolio to realize our business goals in India,” said Ahmet C. Bozer, executive vice-president of Coca-Cola. The company is anticipating that India will be among the top five markets globally in the near future, up two positions from its current rank, said Bozer. who was in Delhi on Thursday to celebrate 20 years of Coca-Cola’s operations in India and to inaugurate a bottling plant in Greater Noida.
The company could, after evaluating demand and volume growth, even increase investments if required, he said.
In June 2012, company chief executive Muhtar Kent had announced the $5 billion investment in its India business to expand capacity and improve its distribution network in Asia’s third largest economy. The company has 57 bottling plants in India, including the new one that’s owned and operated by franchise Moon Beverages, which has invested more than Rs.140 crore to build the plant.
The new plant will allow the company to make beverages including value-added water and sports drinks, expanding the beverage maker’s existing product portfolio in India.
Bozer said the company’s vision was to double system’s (franchise bottling plants) revenue in India in this decade. “Our ongoing investment in the country is focused on delivering innovation, partnerships and a beverage portfolio that enhances the consumer experience...” he said.
To be sure, India volume growth for the owner of beverage brands including Coca-Cola, Fanta, Spriteand Minute Maid was a feeble 1% in the second quarter of fiscal year 2013 on account of a heavier-than-normal monsoon.
Although foreign investors are holding back on their investments amid concerns over India’s slowing economic growth, Bozer clarified that there would be no slowdown in the execution of the company’s investments in India. “There will be economic ups and downs and that will not affect our investments,” he said.
To be sure, the per-capita consumption of Coca-Cola in India is relatively low at 14 compared with a world average of 94. Per capita consumption is defined by the company as the number of servings of 8 fluid ounces consumed by a person in a year.
Globally, the company sells 3,000 products. “Our portfolio will expand over time,” said Atul Singh, deputy president, Pacific Group, Coca-Cola.
Pinakiranjan Mishra, a partner and national leader, business and risk advisory services, at consulting firm EY, said carbonated beverages are still not the regular thirst-quenchers used by consumers in India unlike in the West. As a category, packaged beverages are under-consumed and under-penetrated.
“There is enough room for existing companies to grow. However, lower price points will spur demand,” he said.
Comment E-mail Print  Share 
First Published: Fri, Aug 23 2013. 12 18 AM IST

Thursday, 22 March 2012

Geneva Health Forum, 18 - 20 April 2012


http://www.ghf12.org/ 



GHF 2012 Edition

Print Friendly

A Critical Shift to Chronic Conditions: Learning From the Frontliners

Chronic diseases are of growing importance. While non-communicable diseases currently seem to be capturing the agenda, both chronic infectious and non-infectious diseases, pose major challenges to health systems in high and low-incomes countries in stable and emergency situations. The long-term nature of many chronic conditions warrants a comprehensive and sustainable health systems response that brings together a trained workforce with appropriate skills, affordable and reliable supplies of medicines and technologies, and empowerment of patients and communities. These new realties reflect the interplay of various factors such as changing lifestyles, economic development and urbanization. The need for a multi-sectorial response has never been greater. These challenges present new opportunities for science and technology to contribute to the improvement of access to health.
This year’s theme is the result of a consultative process involving hundreds of previous participants and partners. While there have been several calls to action, aiming at raising the profile of non communicable diseases, very little has been heard from those at the frontlines. Those, who are already active all over the world in this field, dealing with both chronic communicable and non-communicable diseases.
We intend to give them a voice and keep the health debates pragmatic and grounded in action.
We therefore welcome submissions along the entire health continuum- from upstream multi-sectoral policies for prevention (of chronic conditions) and related risk factors to downstream actions in the health sector for detection and treatment.
Click here for a detailed list of themes covered by the Geneva Health Forum 2012.
Click here to download the GHF 2012 1st Announcement